Atherosclerotic Cardiovascular Disease

Leading experts from cardiorenal metabolic specialties will present the latest research with clinical implications for diabetes, CVD and kidney disease, with a new format this year designed to drive multispecialty discussions.

The South Asian population in the U.S. is one of the fastest-growing minority ethnic groups, and these individuals are a particularly higher-risk population.

Adults with obesity who used semaglutide for weight loss reduced their 10-year risk for atherosclerotic cardiovascular disease, according to findings presented at the European Congress on Obesity.

Adults with a coronary artery calcium score greater than 300 are at an equivalent risk for major CV events as treated patients with established atherosclerotic CVD, supporting the use of high-dose statins in this population, data show.

Among people aged 55 years or older who had a high burden of coronary atherosclerosis, women were at greater risk for a major adverse cardiovascular event than men, researchers reported.

Data show many people with atherosclerotic CVD did not have risk factors monitored during the COVID-19 pandemic, leading to variable outcomes in BP, lipid and glucose control, researchers reported.

PCSK9 inhibition with alirocumab, on top of high-intensity statin therapy, resulted in significant coronary plaque regression among patients with familial hypercholesterolemia and no clinical atherosclerotic CVD, researchers reported.

Assessing odds for subclinical ASCVD by midlife based on maternal inheritance of FH.

Adults with type 2 diabetes and atherosclerotic cardiovascular disease were less likely to need insulin and had a lower insulin dose requirement with 5 mg or 15 mg ertugliflozin daily compared with placebo, according to study data.

NEW ORLEANS — Certain traditional risk factors including severe high cholesterol, diabetes, hypertension and smoking may increase CV risk among those following a low-carbohydrate, high-fat “keto-style diet,” a speaker reported here.